Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Ali Behbahani reported a 9.70% stake in Monte Rosa Therapeutics, Inc. (Schedule 13D/A)
Event Mar 17, 2026 · Filed Mar 19, 2026
Ali Behbahani reported a 9.70% stake in Monte Rosa Therapeutics, Inc., 7,797,030 shares, with active intent on Mar 17, 2026. Filed Mar 19, 2026 (Schedule 13D/A).
- Stake
- 9.70%
- Shares
- 7,797,030
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| New Enterprise Associates 17, L.P. | 9.60% | 7,692,298 |
| NEA Partners 17, L.P. | 9.60% | 7,692,298 |
| NEA 17 GP, LLC | 9.60% | 7,692,298 |
| Forest Baskett | 9.60% | 7,692,298 |
| Ali Behbahani | 9.70% | 7,797,030 |
| Carmen Chang | 9.60% | 7,692,298 |
| Anthony A. Florence, Jr. | 9.60% | 7,692,298 |
| Mohamad H. Makhzoumi | 9.60% | 7,692,298 |
| Edward T. Mathers | 9.60% | 7,692,298 |
| Scott D. Sandell | 9.60% | 7,692,298 |
| Paul Walker | 9.60% | 7,692,298 |
| Rick Yang | 9.60% | 7,692,298 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Behbahani Ali
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026